Serum neuron-specific enolase in the major subtypes of status epilepticus

Neurology

Volumn 52, Issue 4, 1999, Pages 746-749

  DeGiorgio, Christopher M ^a,b   Heck, C N ^a   Rabinowicz, A L ^a   Gott, P S ^a   Smith, T ^a   Correale, J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b USC UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEURON SPECIFIC ENOLASE;

ARTICLE; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE CLASSIFICATION; DISEASE MARKER; ENZYME ASSAY; EPILEPTIC STATE; GRAND MAL SEIZURE; HUMAN; INJURY SCALE; MYOCLONUS SEIZURE; PRIORITY JOURNAL;

EID: 0033541074     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.4.746     Document Type: Article

References (14)

1. Krumholz A, Sung GY, Fisher RS, Barry E, Bergey GK, Grattan LM. Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology 1995;45:1499-1504.
2. DeGiorgio CM, Gott PS, Rabinowicz AL, et al. Neuron specific enolase, a marker of acute neuronal injury, is increased in complex partial status epilepticus. Epilepsia 1996;37:606-609.
3. Doose H, Volzke E. Petit mal status in early childhood and dementia. Neuropediatrics 1989;10:10-14.
4. Marangos P, Zis A, Clak R, et al. Neuronal, non-neuronal and hybrid forms of enolase in brains: structural, immunological and functional comparisons. Brain Res 1978;150:117-133.
5. Schmechel D, Marangos PJ, Zis AP, Brightman M, Goodwin FK. Brain enolases as specific markers of neuronal and glial cells. Science 1978;199:313-315.
6. Zomzely-Neurath CE. Nervous system proteins: 14-3-2 protein, antigen alpha and neuron specific enolase. Scand J Immunol 1982;9(suppl 9):1-40.
7. Shimizu A, Suzuki F, Kato K. Characterization of alpha alpha, beta beta, gamma gamma, and alpha gamma human enolase isoenzymes and preparation of hybrid enolase (alpha gamma, beta gamma and alpha beta) from homodimeric forms. Biochem Biophys Acta 1983;748:278-284.
8. DeGiorgio CM, Correale JD, Gott PS, et al. Serum neuron specific enolase in human status epilepticus. Neurology 1995; 45:1134-1137.
9. Correale J, Rabinowicz AL, Heck CN, et al. Status epilepticus increases CSF levels of neuron specific enolase and alters the blood brain barrier. Neurology 1998;50:1388-1391.
10. Sankar R, Shin DH, Wasterlain CG. Serum neuron specific enolase is a marker for neuronal damage following status epilepticus in the rat. Epilepsy Res 1997;28:129-136.
11. Treiman DM. Generalized convulsive status epilepticus. In: Engel J, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997:669-680.
12. Jennet B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-484.
13. Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol 1995;12:326-342.
14. Meldrum BS. Metabolic factors during prolonged seizures and their relation to nerve cell death. In: Delgado Escueta AV, Wasterlain CG, Treiman DM, eds. Advances in neurology: status epilepticus. New York: Raven Press, 1983:261-275.